Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
Clinical trial NCT04798339 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04798339
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2025-05-26
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.